Title | Geography | Industry | ||||
---|---|---|---|---|---|---|
Number of ongoing Clinical Trials (for drugs) involving Achromatopsia by Phase | Other Industry Indicators | Canada | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Down Syndrome by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Osteogenesis Imperfecta by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Fragile X Syndrome by Phase | Other Industry Indicators | New Zealand | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Usher Syndrome by Phase | Other Industry Indicators | Belgium | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Fabry Disease by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Hemochromatosis by Phase | Other Industry Indicators | Spain | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Turner Syndrome by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Alport Syndrome by Phase | Other Industry Indicators | Australia | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Alagille Syndrome by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Duchenne Muscular Dystrophy by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Polycystic Kidney Disease by Phase | Other Industry Indicators | South Korea | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Chronic Granulomatous Disease by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Hypophosphatasia by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Adrenomyeloneuropathy (AMN) by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Recessive X Chromosome Disorders by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Inherited Metabolic Disorders by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Genetic Disorders by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Congenital Ichthyosis by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Hereditary Coproporphyria by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Sandhoff Disease (Jatzkewitz-Pilz Syndrome) by Phase | Other Industry Indicators | Spain | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Glycogen Storage Disorders (GSD) by Phase | Other Industry Indicators | China | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Congenital Disorder of Glycosylation by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Molybdenum Cofactor Deficiency Type A (MOCODA) by Phase | Other Industry Indicators | Malaysia | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Cystinuria by Phase | Other Industry Indicators | France | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Chediak-Higashi Syndrome by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Gaucher Disease Type II by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Mutational Disorders by Phase | Other Industry Indicators | United Kingdom | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Benign Familial Pemphigus (Hailey-Hailey Disease) by Phase | Other Industry Indicators | France | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Neurofibromatoses by Phase | Other Industry Indicators | Netherlands | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Molybdenum Cofactor Deficiency (MOCD) by Phase | Other Industry Indicators | Tunisia | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Adenosine Deaminase Deficiency by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Familial Adenomatous Polyposis by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Gaucher Disease Type I by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Prader-Willi Syndrome (PWS) by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Neonatal Onset Multisystem Inflammatory Disease by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Cryopyrin-Associated Periodic Syndromes by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Ornithine-Transcarbamylase Deficiency by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Lysosomal Storage Disorder by Phase | Other Industry Indicators | Australia | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Malignant Hyperthermia by Phase | Other Industry Indicators | Hong Kong | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Inherited Neurodegenerative Diseases by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Porphyria (Erythropoietic Protoporphyri) by Phase | Other Industry Indicators | United Kingdom | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Lysosomal Acid Lipase Deficiency by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C by Phase | Other Industry Indicators | Israel | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Carbohydrate Metabolism Disorders by Phase | Other Industry Indicators | Taiwan | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Familial Lipoprotein Lipase Deficiency by Phase | Other Industry Indicators | Canada | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Hutchinson-Gilford Progeria by Phase | Other Industry Indicators | Japan | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Neurofibromatoses Type I (Von Recklinghausen’s Disease) by Phase | Other Industry Indicators | Russia | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
Number of ongoing Clinical Trials (for drugs) involving Mucopolysaccharidosis by Phase | Other Industry Indicators | Malaysia | Number of clinical trials for drugs | Healthcare | Oct 2021 |
Still looking?
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Explorer
Access more premium companies when you subscribe to Explorer